Øresund Pharma ApS
Private limited companyCVR 39492059NordhavnActive
Øresund Pharma ApS is a private limited company, based in Nordhavn, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2018. Net profit fell 53% from 2024 to 2025, ending at DKK 6.5m. Equity grew to DKK 44.6m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Net profit fell 53% (2024 → 2025), to DKK 6.5m.
- Equity rose 17% (2024 → 2025), to DKK 44.6m.
Employees
- 4 more employees than a year earlier: 21 (07/2026) against 17 (07/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,755 | 7,275 | 17,238 | 38,260 | 39,622 | 39,702 | +0.2% |
| Operating profit (EBIT) | −21 | 810 | 6,118 | 21,942 | 17,636 | 9,133 | −48.2% |
| Profit before tax | −25 | 412 | 5,523 | 21,483 | 17,634 | 8,358 | −52.6% |
| Net profit | −86 | 281 | 4,302 | 16,751 | 13,707 | 6,467 | −52.8% |
| Total assets | 23,025 | 23,913 | 30,951 | 42,518 | 81,089 | 127,580 | +57.3% |
| Equity | 3,109 | 3,390 | 7,692 | 24,443 | 38,151 | 44,618 | +17% |
| Liabilities | 19,866 | 20,499 | 23,258 | 18,075 | 42,863 | 82,784 | +93.1% |
| Cash and cash equivalents | 3 | 43 | 4 | 9,391 | 557 | 135 | −75.8% |
| Average number of employees | 4 | 5 | 6 | 9 | 11 | 16 | +45.5% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 20/02/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 13/02/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 05/03/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 14/02/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 26/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 01/07/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 20–49 employees9,922 companies in the comparison | No. 742of 9,892 Better than 93% | No. 794of 9,922 Better than 92% |
| Same industry and 20–49 employees47 companies in the comparison | No. 25of 47 Better than 48% | No. 15of 47 Better than 70% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 916of 33,588 Better than 97% | No. 1,308of 33,687 Better than 96% |
| All companies of type ApS66,508 companies in the comparison | No. 987of 66,379 Better than 99% | No. 2,308of 66,505 Better than 97% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Øresund Pharma ApSDKK 39.7m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Øresund Pharma ApSDKK 6.5m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Øresund Pharma ApSDKK 44.6m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Øresund Pharma ApS21
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Machpali ApS90%
- ESH Holding 2019 ApS10%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Patrick Halborg Cohn | CEO | 17/04/2018 |
| Svend Aage Johansen | Director | 01/04/2024 |
- Founders
- Machpali ApS
Signing rule: Virksomheden tegnes af en direktør alene
Address and production units
1 active production unitsOrient Plads 1
2150 Nordhavn
København Municipality · Postcode 2150
Other companies at the address (2)
- Dancontainer A/SRenting and leasing of other machinery, equipment and tangible goods, not for events
- PD Holding A/SOther transportation support activities
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Øresund Pharma ApS | Orient Plads 1, 2150 Nordhavn | 21 | 1023528599 |
Purpose
Selskabets formål er at udvikle og kommercialisere farmaceutiske lægemidler og dermed forbunden virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
18 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20243 changesaddress 1 · management 1 · accounts 1
- AddressMoved to Orient Plads 1, 2150 Nordhavn
- ManagementSvend Aage Johansen appointed director
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20204 changescapital 1 · ownership 3
- CapitalShare capital changed from 50,000 DKK to 55,600 DKK
- OwnershipMachpali ApS registered as owner (90%)
- OwnershipESH Holding 2019 ApS registered as owner (10%)
- OwnershipMachpali ApS is no longer registered as owner
20191 changeaddress 1
- AddressMoved to Dronningens Tværgade 9, 3, 1302 København K
20185 changesname 1 · capital 1 · founded 1 · management 1 · ownership 1
- NameName changed from Øresund Pharma IVS to Øresund Pharma ApS
- CapitalShare capital changed from 500 DKK to 50,000 DKK
- FoundedRegistered as Øresund Pharma IVS
- ManagementPatrick Halborg Cohn appointed ceo
- OwnershipMachpali ApS registered as owner (100%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Same people in management
- Chr. Olesen Synthesis A/Svia Svend Aage Johansen
- Dli - Dansk Lægemiddel Information A/Svia Svend Aage Johansen
- Tpr-group ApSvia Svend Aage Johansen
- Axel Mattsson's Rideskole & Hestepension ApSvia Patrick Halborg Cohn
- Strides Nordic ApSvia Patrick Halborg Cohn
- Pharmanovia A/Svia Svend Aage Johansen
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.